SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-080927
Filing Date
2022-07-20
Accepted
2022-07-19 20:09:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 tm2221368-1_424b5.htm 424B5 553859
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 22578
3 GRAPHIC tm2221368d1-tbl_develop4clr.jpg GRAPHIC 65734
4 GRAPHIC tm2221368d1-tbl_poduct4clr.jpg GRAPHIC 66250
5 GRAPHIC tm2221368d1-tbl_gabab4clr.jpg GRAPHIC 179231
6 GRAPHIC tm2221368d1-tbl_early4clr.jpg GRAPHIC 107700
  Complete submission text file 0001104659-22-080927.txt   1163587
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262050 | Film No.: 221092592
SIC: 2834 Pharmaceutical Preparations